Image 2_Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.jpeg by Yohan Seo (773204)

“…<p>Colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) remain among the most challenging malignancies to treat due to therapy complexity, adverse events, and dose-limiting toxicities, which often result in treatment failure. …”

Image 5_Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.jpeg by Yohan Seo (773204)

“…<p>Colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) remain among the most challenging malignancies to treat due to therapy complexity, adverse events, and dose-limiting toxicities, which often result in treatment failure. …”

Image 1_Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.jpeg by Yohan Seo (773204)

“…<p>Colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) remain among the most challenging malignancies to treat due to therapy complexity, adverse events, and dose-limiting toxicities, which often result in treatment failure. …”

Supplementary Material for: A Case Report of Intravitreal Aflibercept for Iris Metastasis from Small Cell Lung Carcinoma with Neovascular Glaucoma by figshare admin karger (2628495)

“…Case Presentation A 65-year-old man with small cell lung carcinoma (SCLC) presented with right ocular pain and blurred vision. …”

Data Sheet 1_Iron modulates barrier integrity and stem cell function of small intestine during experimental colitis.docx by Shubin Wang (3105348)

“…</p>Results<p>It was shown that during DSS-induced colitis, small intestine underwent a serious injury process, including dysregulated integrity and decreased proliferation of ISCs. …”

Frequencies of regulatory T cell in mice transplanted with feces from donors with intestinal protists. by Oswaldo Partida-Rodríguez (734406)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Cytokine production in mice transplanted with feces from people with intestinal protists. by Oswaldo Partida-Rodríguez (734406)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Relative gene expression of epithelial integrity markers in the intestines of mice transplanted with human feces containing intestinal protists. by Oswaldo Partida-Rodríguez (734406)

Subjects:

TNF production and the frequency of CD8+ T cells in the spleens of mice transplanted with feces from individuals with intestinal protists. by Oswaldo Partida-Rodríguez (734406)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Cytokine production in mice transplanted with gut bacteriome material from individuals parasitized with intestinal protozoa. by Oswaldo Partida-Rodríguez (734406)

Subjects:

The colonic mucus layer in the intestines of mice transplanted with feces from individuals with intestinal protists. by Oswaldo Partida-Rodríguez (734406)

Subjects: